Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Rational Design of Vaccines Against Hepatitis C Virus (U19…

U.S. National Institutes of Health·United States of America

Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)

Closes 11/7/2025$2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is soliciting applications for a consortium of Research Centers focused on designing, optimizing, evaluating, and developing broadly protective vaccines for hepatitis C virus (HCV) to enable the advancement of vaccine candidates into clinical evaluation. The application deadline is November 7, 2025. Key aspects of this opportunity include: • The development of broadly protective vaccines for HCV • The advancement of vaccine candidates into clinical evaluation • A consortium of Research Centers will be established • Applications are due by November 7, 2025 • The estimated funding for this opportunity is $8,300,000 • The award is expected to be made on July 1, 2026 • The project duration is expected to be around 5 years

Attached files

Contact

Rajeev Gautam(Program Contact)

[email protected]

(301) 761-5347

Key dates

Opened
5/27/2025
Closes
11/7/2025
Projected award
7/1/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-AI-25-012

Budget estimate

$2,000,000

The Award Ceiling is explicitly stated on the source site.

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Centers for Disease Control - NCHHSTP·United States of America

Top match · 66%

Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)

Closes 3/17/2027Opened 6/9/2026

U.S. Centers for Disease Control - NCHHSTP·United States of America

65% match

National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers

Closes 6/30/2027Opened 7/9/2026

U.S. National Institutes of Health·United States of America

63% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

63% match

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/18/2026

U.S. National Institutes of Health·United States of America

63% match

Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

Closes 11/10/2026Opened 3/10/2026

U.S. National Institutes of Health·United States of America

63% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

63% match

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 4/9/2026

U.S. National Institutes of Health·United States of America

63% match

Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

Closes 1/24/2027Opened 7/16/2026

U.S. National Institutes of Health·United States of America

62% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

62% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

62% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

U.S. National Institutes of Health·United States of America

62% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. Centers for Disease Control-GHC·United States of America

61% match

Capacity Building for Global, Regional, and National Immunization Programs

Closes 3/13/2027Opened 8/14/2026

U.S. Food and Drug Administration·United States of America

61% match

Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/29/2023

U.S. National Institutes of Health·United States of America

61% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

Mental Health, NYS Office of·New York

61% match

IFB 26-067 FLU/PCR, CT/NG PCR and HCV/PCR Testing

Closes 12/3/2026Opened 10/16/2026

U.S. Centers for Disease Control-GHC·United States of America

61% match

Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

Closes 3/13/2027Opened 8/31/2026

U.S. National Institutes of Health·United States of America

61% match

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

Closes 5/26/2029Opened 9/17/2025

U.S. Department Of Health And Human Services·United States of America

61% match

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

Closes 12/8/2026Opened 10/9/2026

U.S. Food and Drug Administration·United States of America

61% match

Center for Research on Complex Generics (U18) Clinical Trials Optional

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

61% match

Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 5/28/2027Opened 12/22/2025

U.S. National Institutes of Health·United States of America

61% match

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Closes 11/17/2026Opened 12/20/2023

U.S. National Institutes of Health·United States of America

61% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

61% match

Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network

Closes 1/29/2027Opened 7/28/2026

U.S. Food and Drug Administration·United States of America

60% match

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/21/2023